Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tran

Showing results (1321-1330 of 1,413) with videos related to

Pageof 142
Sort By:
AJR. American Journal of Roentgenology|October 9, 2019
Dose Reduction in Molecular Breast Imaging With a New Image-Processing AlgorithmAshley T Tao, Carrie B Hruska, Amy L Conners, et al.
Theranostics|April 1, 2020
Aptamer-guided extracellular vesicle theranostics in oncologyPhuong H-L Tran, Dongxi Xiang, Tuong N-G Nguyen, et al.
Journal of Medicinal Chemistry|October 19, 2001
Synthesis and antitumor activity of ester-modified analogues of bengamide BF R Kinder, R W Versace, K W Bair, et al.
Disease Markers|October 2, 2015
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain TumorsAndrei G Vlassenko, Jonathan McConathy, Lars E Couture, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2015
Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomideChristina K Speirs, Joseph R Simpson, Clifford G Robinson, et al.
Nature Communications|March 9, 2024
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylationCang Li, Zhengyu Wang, Licheng Yao, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Neuro-Oncology Advances|January 6, 2022
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastomaOmar H Butt, Alice Y Zhou, Jiayi Huang, et al.
Nature Communications|August 12, 2021
CTCF is a barrier for 2C-like reprogrammingTeresa Olbrich, Maria Vega-Sendino, Desiree Tillo, et al.
Pediatric Blood & Cancer|October 10, 2013
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman diseaseStephen J Simko, Huy D Tran, Jeremy Jones, et al.
Pageof 142

Showing results (1321-1330 of 1,413) with videos related to

Sort By:
Pageof 142
AJR. American Journal of Roentgenology|October 9, 2019
Dose Reduction in Molecular Breast Imaging With a New Image-Processing AlgorithmAshley T Tao, Carrie B Hruska, Amy L Conners, et al.
Theranostics|April 1, 2020
Aptamer-guided extracellular vesicle theranostics in oncologyPhuong H-L Tran, Dongxi Xiang, Tuong N-G Nguyen, et al.
Journal of Medicinal Chemistry|October 19, 2001
Synthesis and antitumor activity of ester-modified analogues of bengamide BF R Kinder, R W Versace, K W Bair, et al.
Disease Markers|October 2, 2015
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain TumorsAndrei G Vlassenko, Jonathan McConathy, Lars E Couture, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2015
Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomideChristina K Speirs, Joseph R Simpson, Clifford G Robinson, et al.
Nature Communications|March 9, 2024
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylationCang Li, Zhengyu Wang, Licheng Yao, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Neuro-Oncology Advances|January 6, 2022
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastomaOmar H Butt, Alice Y Zhou, Jiayi Huang, et al.
Nature Communications|August 12, 2021
CTCF is a barrier for 2C-like reprogrammingTeresa Olbrich, Maria Vega-Sendino, Desiree Tillo, et al.
Pediatric Blood & Cancer|October 10, 2013
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman diseaseStephen J Simko, Huy D Tran, Jeremy Jones, et al.
Pageof 142